Insider filing · TNGX
Barbara Weber
Director, Executive Chair
profile →
Tango Therapeutics, Inc.
TNGX · Healthcare · 23 filings in 24 months
ticker →
Barbara Weber sold $370K of Tango Therapeutics (TNGX)
Executed Feb 3, disclosed Feb 4, 1 day later.
Value, as filed
$370K
30,186 sh × $12.26
Executed
Feb 3
the trade date, as filed
Disclosed
Feb 4
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BWBarbara Weber (Director, Executive Chair) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $370K of TNGX (30,186 sh × $12.26, as filed), executed Feb 3.
The name
TNGXHealthcare · Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations wi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→